AT1-receptor blockade and sympathetic neurotransmission in cardiovascular disease

Autonomic and Autacoid Pharmacology

Volumn 23, Issue 5-6, 2003, Pages 285-296

  Nap, A ^a   Balt, J C ^a   Mathy, M J ^a   Van Zwieten, P A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin; Cardiovascular disease; Postsynaptic AT1 receptors; Presynaptic AT1 receptors; Renin angiotensin aldosterone system; Sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 1 (4 AMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDROIMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ADRENALIN; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPROSARTAN; IRBESARTAN; LOSARTAN; NORADRENALIN; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; TELMISARTAN; TYRAMINE; VALSARTAN;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL TISSUE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CATECHOLAMINE RELEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; DOSE RESPONSE; ELECTROSTIMULATION; HYPERTENSION; LOWER BODY NEGATIVE PRESSURE; MOUSE; NONHUMAN; RABBIT; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MODELS, BIOLOGICAL; RECEPTOR, ANGIOTENSIN, TYPE 1; SYMPATHETIC NERVOUS SYSTEM;

EID: 3442886917     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2004.00301.x     Document Type: Review

References (90)

1. ALLEN, A.M., MACGREGOR, D.P., MCKINLEY, M.J. & MENDELSOHN, F.A. (1999). Angiotensin II receptors in the human brain. Regul. Pept., 79, 1-7.
2. ANDREWS, C.O., CRIM, J.W. & HARTLE, D.K. (1993). Angiotensin II binding in area postrema and nucleus tractus solitarius of SHR and WKY rats. Brain Res. Bull., 32, 419-424.
3. BALT, J.C., MATHY, M.J., NAP, A., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2001). Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J. Cardiovasc. Pharmacol., 38, 141-148.
4. BALT, J.C., MATHY, M.J., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2001a). Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril. J. Hypertens., 19, 465-473.
5. BALT, J.C., MATHY, M.J., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2001b). Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan. J. Hypertens., 19, 2241-2250.
6. BALT, J.C., MATHY, M.J., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2002a). Sympatho-inhibitory properties of various AT1 receptor antagonists. J. Hypertens., 20 (Suppl 5), S3-S11.
7. BALT, J.C., MATHY, M.J., NAP, A., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2002b). Prejunctional and posrjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery. J. Cardiovasc. Pharmacol., 40, 50-57.
8. BALT, J.C., BELTERMAN, C.N., MATHY, M.J., NAP, A., BAARTSCHEER, A., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2003). Decreased facilitation by angiotensin II of noradrenergic neurotransmission in isolated mesenteric artery of rabbits with chronic heart failure. J. Cardiovasc. Pharmacol., 41, 356-362.
9. BENEDICT, C.R., SHELTON, B., JOHNSTONE, D.E., FRANCIS, G., GREENBERG, B., KONSTAM, M., PROBSTFIELD, J.L. & YUSUF, S. (1996). Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation, 94, 690-697.
10. CAMPBELL, D.J., AGGARWAL, A., ESTER, M. & KAYE, D. (2001). beta-blockers, angiotensin II, and ACE inhibitors in patients with heart failure. Lancet, 358, 1609-1610.
11. CHRISTOPHE, B., LIBON, R., CAZAUBON, C., NISATO, D., MANNING, A. & CHATELAIN, P. (1995). Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action. Eur. J. Pharmacol., 281, 161-171.
12. CLOUGH, D.P., HATTON, R., KEDDIE, J.R. & COLLIS, M.G. (1982). Hypotensive action of captopril in spontaneously hypertensive and normorensive rats. Interference with neurogenic vasoconstriction. Hypertension, 4, 764-772.
13. CODY, R.J., FRANKLIN, K.W., KLUGER, J. & LARAGH, J.H. (1982). Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril. Am. J. Med., 72, 791-797.
14. COHN, J.N. & TOGNONI, G. (2001). A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N. Engl. J. Med., 345, 1667-1675.
15. COLLIS, M.G., DE MAY, C. & VANHOUTTE, P.M. (1979). Enhanced release of noradrenaline in the kidney of the young spontaneously hypertensive rat. Clin. Sci. (Lond.), 57 (Suppl. 5), s233-s234.
16. COX, S.L., BEN, A., STORY, D.F. & ZIOGAS, J. (1995). Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. Br. J. Pharmacol., 114, 1057-1063.
17. COX, S.L., STORY, D.F. & ZIOGAS, J. (1996). Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat. Br. J. Pharmacol., 119, 976-984.
18. CROZIER, I., IKRAM, H., AWAN, N., CLELAND, J., STEPHEN, N., DICKSTEIN, K., FREY, M., YOUNG, J., KLINGER, G. & MAKRIS, L. (1995). Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group. Circulation, 91, 691-697.
19. DANG, A., ZHENG, D., WANG, B., ZHANG, Y., ZHANG, P., XU, M., LIU, G. & LIU, L. (1999). The role of the reninangiotensin and cardiac sympathetic nervous systems in the development of hypertension and left ventricular hypertrophy in spontaneously hypertensive rats. Hypertens. Res., 22, 217-221.
20. DE JONGE, A., KNAPE, J.T., VAN MEEL, J.C., KALKMAN, H.C., WILFFERT, B., THOOLEN, M.J., TIMMERMANNS, P.B. & VAN ZWIETEN, P.A. (1982). Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2- adrenoceptor stimulation in pithed normotensive rats. Naunyn Schmiedebergs Arch. Pharmacol., 321, 309-313.
21. DENDORFER, A., RAASCH, W., TEMPEL, K. & DOMINIAK, P. (2002). Comparison of the vascular and antiadrenergic activities of four angiotensin II type 1 antagonists in the pithed rat. J. Hypertens., 20, 1151-1156.
22. DUCKLES, S.P. (1981). Angiotensin II potentiates responses of the rabbit basilar artery to adrenergic nerve stimulation. Life Sci., 28, 635-640.
23. DUDLEY, D.T., PANEK, R.L., MAJOR, T.C., LU, G.H., BRUNS, R.F., KLINKEFUS, B.A., HODGES, J.C. & WEISHAAR, R.E., (1990). Subclasses of angiotensin II binding sites and their functional significance. Mol. Pharmacol., 38, 370-377.
24. ERNSBERGER, P., ZHOU, J., DAMON, T.H., & DOUGLAS, J.G. (1992). Angiotensin II receptor subtypes in cultured rat renal mesangial cells. Am. J. Physiol., 263, F411-F416.
25. ESLER, M., LAMBERT, G. & JENNINGS, G. (1990). Increased regional sympathetic nervous activity in human hypertension: causes and consequences. J. Hypertens. Suppl., 8, S53-S57.
26. ESLER, M., KAYE, D., LAMBERT, G., ESLER, D. & JENNINGS, G. (1997). Adrenergic nervous system in heart failure. Am. J. Cardiol., 80, 7L-14L.
27. FARR, W.C., & GRUPP, G. (1971). Ganglionic stimulation: mechanism of the positive inotropic and chronotropic effects of angiotensin. J. Pharmacol. Exp. Ther, 177, 48-55.
28. FOUCART, S., DE CHAMPLAIN, J. & NADEAU, R. (1991). Modulation by beta-adrenoceptors and angiotensin II receptors of splanchnic nerve evoked catecholamine release from the adrenal medulla. Can. J. Physiol. Pharmacol., 69, 1-7.
29. GOTTLIEB, S.S., DICKSTEIN, K., FLECK, E., KOSTIS, J., LEVINE, T.B., LEJEMTEL, T. & DEKOCK, M. (1993). Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation, 88, 1602-1609.
30. GRANT, T.L. & MCGRATH, J.C. (1988). Interactions between angiotensin II and alpha-adrenoceptor agonists mediating pressor responses in the pithed rat. Br. J. Pharmacol., 95, 1229-1240.
31. GRASSI, G. (1998). Role of the sympathetic nervous system in human hypertension. J. Hypertens., 16, 1979-1987.
32. GRASSI, G., CATTANEO, B.M., SERAVALLE, G., LANFRANCHI, A., POZZI, M., MORGANTI, A., CARUGO, S. & MANCIA, G. (1997). Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation, 96, 1173-1179.
33. GRASSI, G., TURRI, C., DELL'ORO, R., STELLA, M.L., BOLLA, G.B. & MANCIA, G. (1998). Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension. J. Hypertens., 16, 1789-1796.
34. GROSSMAN, PELEG, E., PELEG, E., CARROLL, J., SHAMISS, A. & ROSENTHAL, T. (1994). Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension. Am. J. Hypertens., 7, 1041-1044.
35. GUIMARAES, S., PAIVA, M.Q. & MOURA, D. (1998). Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries. Br. J. Pharmacol., 124, 1207-1212.
36. GUIMARAES, S., PINHEIRO, H., TAVARES, P., LOIO, A. & MOURA, D. (2001). Differential effects of eprosartan and losartan at prejunctional angiotensin II receptors. Naunyn Schmiedebergs Arch. Pharmacol., 363, 509-514.
37. HOUGHTON, A.R., HARRISON, M. & COWLEY, A.J. (1999). Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy. Evaluation of Losartan in the Elderly. Eur. J. Heart Fail., 1, 385-393.
38. JONSSON, J.R., SMID, S.D., FREWIN, D.B. & HEAD, R.J. (1993). Angiotensin II-mediated facilitation of sympathetic neurotransmission in the spontaneously hypertensive rat is not associated with neuronal uptake of the peptide. J. Cardiovasc. Pharmacol., 22, 750-753.
39. JOSEPH, J. & GILBERT, E.M. (1998). The sympathetic nervous system in chronic heart failure. Prog. Cardiovasc. Dis., 41, 9-16.
40. KAMEN, P.W., KRUM, H. & TONKIN, A.M. (1997). Low-dose but not high-dose captopril increases parasympathetic activity in patients with heart failure. J. Cardiovasc. Pharmacol., 30, 7-11.
41. KAWASAKI, H., CLINE, W.H. JR. & SU, C. (1982). Enhanced angiotensin-mediated facilitation of adrenergic neurotransmission in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther, 221, 112-116.
42. KNAPE, J.T. & VAN ZWIETEN, P.A. (1988). Positive chronotropic activity of angiotensin II in the pithed normotensive rat is primarily due to activation of cardiac beta 1-adrenoceptors. Naunyn Schmiedebergs Arch. Pharmacol., 338, 185-190.
43. LEIMBACH, W.N. Jr., WALLIN, B.C., VICTOR, R.G., AYLWARD, P.E., SUNDLOF, G. & MARK, A.L. (1986). Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation, 73, 913-919.
44. LOKHANDWALA, M.F. & EIKENBURG, D.C. (1983). Minireview. Presynaptic receptors and alterations in norepinephrine release in spontaneously hypertensive rats. Life Sci., 33, 1527-1542.
45. MA, X., ABBOUD, F.M. & CHAPLEAU, M.W. (2001). A novel effect of angiotensin on renal sympathetic nerve activity in mice. J. Hypertens., 19, 609-618.
46. MANCIA, G. (1990). Sympathetic activation in congestive heart failure. Eur. Heart. J., 11 (Suppl. A), 3-11.
47. MARK, A.L. (1996). The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J. Hypertens. Suppl., 14, S159-S165.
48. MENDELSOHN, F.A., DOYLE, A.E. & GRAY, G.W. (1980). Lack of response of sympathetic nervous system to angiotensin infusion. Lancet, 1, 492-493.
49. MOAN, A., RISANGER, T., EIDE, I. & KJELDSEN, S.E. (1994). The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension. Blood Press, 3, 185-188.
50. MOREAU, N., RICHER, C., VINCENT, M.P. & GIUDICELLI, J.F. (1993a). Sympathoinhibitory effects of losartan in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol., 22, 126-134.
51. MOREAU, N., RICHER, C., VINCENT, M.P. & GIUDICELLI, J.F. (1993b). [Interaction between SR 47436, a new angiotensin II antagonist and sympathetic nervous system in pithed SHR rats]. Arch. Mal. Coeur. Vaiss., 86, 1269-1274.
52. MURAKAMI, H., LIU, J.L. & ZUCKER, I.H. (1997). Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure. Hypertension, 29, 564-569.
53. NAP, A., BALT, J.C., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2002). Sympatholytic properties of several AT1-receptor antagonists in the isolated rabbit thoracic aorta. J. Hypertens., 20, 1821-1828.
54. NAP, A., BELTERMAN, C.N., MATHY, M.J., BALT, J.C., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2003a). Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model. J. Renin Angiotensin Aldosterone Syst., 4, 220-227.
55. NAP, A., MATHY, M.J., BALT, J.C., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2003b). Pre- and postsynaptic inhibitory potencies of the angiotensin AT1 receptor antagonists eprosartan and candesartan. Eur. J. Pharmacol., 469, 117-124.
56. NAP, A., BALT, J.C., MATHY, M.J., PFAFFENDORF, M. & VAN ZWIETEN, P.A. (2004). Different AT1 receptor subtypes at pre- and postjunctional sites: AT1A versus AT1B receptors. J. Cardiovasc. Pharmacol., 43, 14-20.
57. NEWBY, D.E., GOODFIELD, N.E., FLAPAN, A.D., BOON, N.A., FOX, K.A. & WEBB, D.J. (1998). Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II. Heart, 80, 134-140.
58. NICHOLLS, M.G., ESPINER, E.A., MILES, K.D., ZWEIFLER, A.J. & JULIUS, S. (1981). Evidence against an interaction of angiotensin II with the sympathetic nervous system in man. Clin. Endocrinol. (Oxf), 15, 423-430.
59. OHLSTEIN, E.H., BROOKS, D.P., FEUERSTEIN, G.Z. & RUFFOLO, R.R., Jr. (1997). Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade. Pharmacology, 55, 244-251.
60. PANISSET, J.C. & BOURDOIS, P. (1968). Effect of angiotensin on the response to noradrenaline and sympathetic nerve stimulation, and on 3H-noradrenaline uptake in cat mesenteric blood vessels. Can. J. Physiol. Pharmacol., 46, 125-131.
61. PARK, J.K., KIM, S.Z., KIM, S.H., KIM, Y.G. & CHO, K.W. (2000). Renin angiotensin system of rabbit clitoral cavernosum: interaction with nitric oxide. J. Urol., 164, 556-561.
62. PEACH, M.J. (1971). Adrenal medullary stimulation induced by angiotensin I, angiotensin II, and analogues. Circ. Res., 28 (Suppl. 2), 107-117.
63. PFEFFER, M.A., MCMURRAY, J.J., VELAZQUEZ, E.J. et al. (2003a). Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N. Engl. J. Med., 349, 1893-1906.
64. PFEFFER, M.A., SWEDBERG, K., GRANGER, C.B., HELD, P., MCMURRAY, J.J., MICHELSON, E.L., OLOFSSON, B., OSTERGREN, J., YUSUF, S. & POCOCK, S. (2003b). Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet, 362, 759-766.
65. PURDY, R.E. & WEBER, M.A. (1988). Angiotensin II amplification of alpha-adrenergic vasoconstriction: role of receptor reserve. Circ. Res., 63, 748-757.
66. RAASCH, W., BETGE, S., DENDORFER, A., BARTELS, T. & DOMINIAK, P. (2001). Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats. J. Hypertens., 19, 1827-1833.
67. RAIZADA, M.K., LU, D. & SUMNERS, C. (1995). AT1 receptors and angiotensin actions in the brain and neuronal cultures of normotensive and hypertensive rats. Adv. Exp. Med. Biol., 377, 331-348.
68. RECTOR, T.S., OLIVARI, M.T., LEVINE, T.B., FRANCIS, G.S. & COHN, J.N. (1987). Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am. Heart J., 114, 148-152.
69. REID, I.A. (1992). Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure [editorial]. Am. J. Physiol., 262, E763-E778.
70. RODRIGUEZ-GARCIA, J.L., PAULE, A., DOMINGUEZ, J., GARCIA-ESCRIBANO, J.R. & VAZQUEZ, M. (2000). Changes in plasma norepinephrine and endothelin levels and metabolic profile after AT1-receptor blockade in human hypertension. Am. J. Cardiol., 85, 1147-1150, A10.
71. ROTH, R.H. (1972). Action of angiotensin on adrenergic nerve endings: enhancement of norepinephrine biosynthesis. Fed. Proc., 31, 1358-1364.
72. RUMANTIR, M.S., KAYE, D.M., JENNINGS, G.L., VAZ, M., HASTINGS, J.A. & ESLER, M.D. (2000). Phenotypic evidence of faulty neuronal norepinephrine reuptake in essential hypertension. Hypertension, 36, 824-829.
73. SAKATA, K., YOSHIDA, H., OBAYASHI, K., ISHIKAWA, J., TAMEKIYO, H., NAWADA, R. & DOI, O. (2002). Effects of losartan and its combination with quinapril on the cardiac sympathetic nervous system and neurohormonal status in essential hypertension. J. Hypertens., 20, 103-110.
74. SAXENA, P.R. (1992). Interaction between the reninangiotensin-aldosterone and sympathetic nervous systems. J. Cardiovasc. Pharmacol., 19 (Suppl. 6), S80-S88.
75. SEIDELIN, P.H. & STRUTHERS, A.D. (1991). The effect of angiotensin II on haemodynamic and plasma noradrenaline responses to tyramine infusion in man. Eur. J. Clin. Pharmacol., 41, 119-123.
76. SEIDELIN, P.H., COLLIER, J.G., STRUTHERS, A.D. & WEBB, D.J. (1991). Angiotensin II augments sympathetically mediated arteriolar constriction in man. Clin. Sci. (Lond.), 81, 261-266.
77. SHARPE, N. (1999). Benefit of beta-blockers for heart failure: proven in 1999. Lancet, 353, 1988-1989.
78. SHETTY, S.S. & DELGRANDE, D. (2000). Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan. J. Pharmacol. Exp. Ther., 294, 179-186.
79. STARKE, K., TAUBE, H.D. & BROWSKI, E. (1977). Presynaptic receptor systems in catacholamingergic transmission. Biochem. Pharmacol., 26, 259-268.
80. STRUCK, J., MUCK, P., TRUBGER, D., HANDROCK, R., WEIDINGER, G., DENDORFER, A. & DODT, C. (2002). Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J. Hypertens., 20, 1143-1149.
81. SWEDBERG, K., ENEROTH, P., KJEKSHUS, J. & WILHELIMSEN, L. (1990). Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation, 82, 1730-1736.
82. THOMAS, J.A. & MARKS, B.H. (1978). Plasma norepinephrine in congestive heart failure. Am. J. Cardiol., 41, 233-243.
83. VAN ZWIETEN, P.A. & DE JONGE, A. (1986). Interaction between the adrenergic and renin-angiotensin-aldosterone-systems. Postgrad. Med. J., 62 (Suppl. 1), 23-27.
84. WEINBERGER, M.H. (1982). Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients. Am. J. Cardiol., 49, 1542-1543.
85. WEIR, M.R. & DZAU, V.J. (1999). The renin-angiotensin-aldosterone system: A specific target for hypertension management. Am. J. Hypertension, 12, 205S-213S.
86. WHITEBREAD, S., MELE, M., KAMBER, B. & DE GASPARO, M. (1989). Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun., 163, 284-291.
87. WONG, P.C., HART, S.D., ZASPEL, A.M., CHIU, A.T., ARDECKY, R.J., SMITH, R.D. & TIMMERMANS, P.B. (1990a). Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). J. Pharmacol. Exp. Ther., 255, 584-592.
88. WONG, P.C., PRICE, W.A. JR., CHIU, A.T., DUNCIA, J.V., CARINI, D.J., WEXLER, R.R., JOHNSON, A.L. & TIMMERMANS, P.B. (1990b). Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X. Hypertension, 15, 459-468.
89. WONG, P.C., BERNARD, R. & TIMMERMANS, P.B. (1992). Effect of blocking angiotensin II receptor subtype on rat sym-pathetic nerve function. Hypertension, 19, 663-667.
90. YOKOYAMA, H., MINATOGUCHI, S., KOSHIJI, M., UNIO, Y., KAKAMI, M., NAGATA, C., ITO, H. & FUJIWARA, H. (1997). Losartan and captopril follow different mechanisms to decrease pressor responses in the pithed rat. Clin. Exp. Pharmacol. Physiol, 24, 697-705.